INO therapuetic

Ended Awarded Last action

Contract number
36C24723F0049
Awardee
Awarding agency
Obligated
$207,792

Award facts

Contract value 24% obligated
  • $153,253.62 Current, with exercised options
  • $853,273.62 Potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
PSC
Q999 Medical- Other
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Charleston, SC 29401, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00009 $1,017
Exercise an Option P00006 · INO therapuetic OY3 $80,840
Funding Only Action P00007 -$12,932
Exercise an Option P00005 $93,260
Other Administrative Action P00004 -$59,496
Other Administrative Action P00003 -$93,217
Exercise an Option P00001 $99,160
Other Administrative Action P00002 $0
Original award $99,160

About this award

INO Therapeutics LLC, a foreign-owned supplier of specialized respiratory therapeutic gases headquartered in Hazelwood, Missouri, received a $853,273.62 firm fixed-price delivery order from Veterans Integrated Service Network 7 (VISN 7), a civilian component of the Department of Veterans Affairs. The delivery order, issued on October 1, 2022, with ultimate completion targeted for September 30, 2027, represents a call against the company's existing Blanket Purchase Agreement with VISN 2 under the General Services Administration's Pharmaceuticals and Drugs Supply Schedule (FSS-61-IB). The work will be performed in Charleston, South Carolina, and involves the supply of inhaled nitric oxide (INOMAX) therapeutic gases and related inhalation therapy delivery systems to support critical care patient populations across the VA healthcare system. No set-aside designation was applied to this contract award.

INO Therapeutics has established itself as a critical supplier of specialized medical gases to federal healthcare agencies, with an extensive contract portfolio spanning multiple Veterans Integrated Service Networks and the Defense Health Agency. The company supplies INOMAX cylinders with associated delivery equipment and provides comprehensive inhalation therapy services to neonatal, pediatric, and adult patient populations at VA and military medical facilities nationwide. This delivery order reflects the VA's ongoing requirement for continuous, reliable access to therapeutic nitric oxide supplies necessary to support advanced respiratory care and treatment capabilities across the federal healthcare system.

Quick answers

Who was awarded contract 36C24723F0049?

36C24723F0049 was awarded to INO Therapeutics LLC by Veterans Integrated Service Network 7 (Veterans Health Administration) on October 1, 2022.

How much is contract 36C24723F0049 worth?

The government has obligated $207,792 on 36C24723F0049. Its current value, with exercised options, is $153,254. Its potential value, with all options, is $853,274.

Is contract 36C24723F0049 an order under another contract?

Yes. 36C24723F0049 is a delivery order under V797D60737, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C24723F0049 competed?

The extent of competition for 36C24723F0049 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award